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moderate or severe ichthyosis vulgaris
in 15 families and isolated cases (Smith
et al., 2006). In a recent case report
of six Irish families with ichthyosis
vulgaris and AD, a third FLG mutation,
3702delG, was found in one family in
heterozygous state (Sandilands et al.,
2006). This mutation was not found in
B380 healthy controls. As this muta-
tion appears so rare, we did not
evaluate it in our AD cohort.
In conclusion, we found a significant
association of two FLG loss-of-function
mutations with AD, especially with
early onset of the disease. Thus, we
were able to replicate and extend the
findings of earlier studies, suggesting
that these variations may play an
important role in AD pathogenesis.
Replication studies are highly important
for complex genetic diseases to rule out
that an observed association is not
owing to chance. Further studies in
additional populations will reveal the
precise relationship between FLG var-
iations and atopic disease.
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TO THE EDITOR
Atopic dermatitis (AD) arises from the
interaction between strong genetic and
environmental factors (Morar et al.,
2006). As it commonly occurs in con-
cert with asthma and/or hay fever, and
the majority of patients exhibits ele-
vated serum IgE levels and/or sensitiz-
ations against aero- and food allergens,
most pathophysiological concepts are
dominated by atopic mechanisms and
regard IgE-mediated sensitization as
central cornerstone in the development
of AD (Akdis et al., 2006). However,
there is accumulating evidence from
epidemiological studies, suggesting that
sensitization is not essential for the
development of eczema and that atopy
may be secondary rather than causative
(Williams and Flohr, 2006). In addition,
genome-wide screens and candidate
gene studies have shown only partial
overlap of AD with other atopic pheno-
types, but a closer relationship with
other epithelial diseases such as psoria-
sis (Cookson, 2004). Thus, attention has
been drawn to the impaired epidermal
barrier function, which is a hallmark
feature of AD. In this context, the
epidermal differentiation complex on
chromosome 1q21, for which linkage
to both AD and psoriasis has been
reported, is of particular interest, as it
harbors a number of genes and gene
families expressed in the terminally
differentiating epithelium (Cookson
et al., 2001). Recently, it was demon-
strated that two functional mutations
within the epidermal differentiation
complex gene filaggrin (FLG), underlie
ichthyosis vulgaris (Smith et al., 2006)
and are strong risk factors for AD and
asthma in the context of AD in European
populations (Palmer et al., 2006). In aAbbreviations: AD, atopic dermatitis; FLG, filaggrin
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subsequent family-based association
study, we could show that these muta-
tions particularly predispose to the
extrinsic subtype of AD, but not in-
trinsic AD, suggesting that the skin
barrier defect in AD is a key early event
that precedes the development of aller-
gic sensitization and respiratory atopy
(Weidinger et al., 2006). To replicate
these associations, we investigated an
independent collection of 274 unre-
lated adult AD cases (average age
35.9710.8 years; 61.2% female sub-
jects and 38.8% male subjects) and
252 population-based controls (average
age 39.4716.1 years; 61.5% female
subjects and 38.5% male subjects). All
patients were recruited in the dermato-
logic outpatient departments of the
University of Bonn and the Technical
University Munich, Germany. AD was
diagnosed on the basis of a skin
examination by experienced dermato-
logists using the UK diagnostic criteria
for AD. The severity of eczema was
assessed using the SCORAD (scor-
ing atopic dermatitis index). Subjects
were classified as having asthma or
allergic rhinitis when they reported a
physician’s diagnosis of asthma or
rhinoconjunctivitis. Hypernormal con-
trol individuals without AD or allergic
diseases and IgE levelso100 kU/l were
selected from the KORA S4 (Coopera-
tive Health Research in the Region of
Augsburg Survey 4: 1999–2001) popu-
lation-based cross-sectional study,
which was carried out 1999–2001 in
the city and region of Augsburg, South
Germany (Weidinger et al., 2005).
Total as well as specific IgE antibodies
against common environmental aller-
gens were measured with the help of
an enzyme-immuno assay (CAP-FEIA,
Pharmacia, Uppsala, Sweden). Specific
sensitization was defined to be present
if at least one of the specific IgE anti-
bodies was positive (CAP-RAST class
X1, corresponding to X0.35 kU/l). A
raised total serum IgE was taken to be
greater than 100 kU/l. Extrinsic AD was
defined as AD with concomitant sensi-
tization and/or IgE levels X100 kU/l.
Severity of AD was regarded as binary
trait using the median value of the
objective SCORAD components (31
points) as cutoff.
All study methods were approved by
the ethics committee of the ‘‘Bayerische
Landesa¨rtzekammer’’ Munich and the
ethics committee of the University of
Bonn and a written and informed
consent that complies with all the
Declaration of Helsinki Principles was
obtained from the participants before
the beginning of the study.
Out of the 274 AD cases, 71.7%
were extrinsic, 62.6% had allergic
rhinitis, 34.8% suffered from asthma,
and 41.6% showed an early onset of the
disease (o2 years of age). The mean
total IgE of AD cases was 1,024 kU/l.
Genotyping for R501X and
2282del4 was performed using the
MassARRAY system (Sequenom, San
Diego, CA) as described previously
(Weidinger et al., 2005). To test for
associations with binary traits, logistic
regression models were applied with
age, sex, and genotype as independent
variables. In addition, associations with
Table 1. Frequency of FLG null alleles in cases (AD) and controls
R501X 2282del4 Combined genotype
Genotype Cases Controls Cases Controls Cases Controls
AA 250 (91.9%) 245 (97.6%) 227 (84.1%) 241 (96.4%) 213 (78.9%) 234 (94.0%)
Aa 22 (8.1%) 6 (2.39%) 43 (15.9%) 9 (3.6%) 50 (18.5%) 15 (6.0%)
aa 7 (2.6%)
Abbreviations: AD, atopic dermatitis; FLG, filaggrin.
‘‘AA’’ refers to wild-type/wild-type FLG genotype for R501X and 2282del4 variants. ‘‘Aa’’ refers to heterozygous genotype for either R501X or 2282del4 and
‘‘aa’’ refers to homozygous R501X or 2282del4 genotype or compound heterozygous genotype.
Table 2. Results of the logistic regression models adjusted for age and sex using backward variable selection
R501X 2282del4 Combined genotype Aa
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
AD 3.51 (1.39; 8.84) 0.0079 4.98 (2.37; 10.48) 2.3 105 3.53 (1.92; 6.48) 4.9105
Extrinsic AD 4.02 (1.58; 10.26) 0.0035 5.00 (2.34; 10.69) 3.3 106 3.66 (1.96; 6.83) 4.6105
AD+asthma 5.07 (1.73; 14.81) 0.0030 7.49 (3.18; 17.63) 4.0 106 5.69 (2.76; 11.73) 2.5106
AD+rhinitis 4.10 (1.55; 10.87) 0.0045 5.83 (2.68; 12.68) 8.9 106 4.04 (2.11; 7.72) 2.4105
Total IgE NS 3.29 (1.56; 6.97) 0.0018 2.14 (1.14; 4.00) 0.0178
Early-onset AD 5.66 (2.05; 15.62) 0.0008 7.18 (3.17; 16.25) 2.3 106 5.21 (2.61; 10.40) 2.8106
SCORAD (objective
components, median
431)
NS 3.16 (1.49; 6.72) 0.0027 2.65 (1.36; 5.17) 0.0043
Abbreviations: AD, atopic dermatitis; CI, confidence interval; NS, nonsignificant; OR, odds ratio.
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IgE levels were evaluated using a linear
regression model on log-transformed
IgE values with the same covariates.
For either regression analysis backward
variable selection was applied. Results
are given for the estimates of genotype
effects after variable selection. The
P-values are two-sided and subject to
a significance level of 0.05. The issue of
multiple testing does not affect the
overall results and interpretation.
Therefore P-values were not adjusted.
In our cohort, we did not observe
any homozygotes for either mutation,
but seven compound heterozygotes.
The FLG variants were greatly over-
represented in AD cases with a com-
bined carrier frequency of 57 (21.1%)
vs 15 (6.0%) in controls (odds ratio
3.53, 95% confidence interval
1.92–6.48, P¼ 4.9105, Tables 1
and 2). The lower than expected carrier
frequency for heterozygote FLG status
in controls (6 vs 10% for other compar-
able populations) is probably due to the
fact that our control population had
been screened so as to not have AD,
allergic diseases or raised IgE levels and
therefore represents a hypernormal type
of control population.
The combined carrier frequency
among patients with extrinsic AD was
24.6%. The highest carrier frequency
was seen in patients with early onset of
disease (33 out of 111, 29.7%). In
addition, logistic regression analysis
indicated that the 2282del4 mutation
was associated with a more severe
phenotype (odds ratio 3.16, 95% con-
fidence interval 1.49–6.72, P¼ 0.0027).
The lack of association with severity for
R501X may be due to the age at which
SCORAD was determined and due to
the fact that the SCORAD is a ‘‘snap
shot’’ variable that does not reflect the
overall disease activity. Both FLG var-
iants showed significant associations
with total serum IgE levels with geo-
metric means for serum IgE (kU/l) 135.6
in wild type/wild type versus 317.4 in
carriers of at least one mutation
(P¼0.010). This association is con-
firmed by linear regression using log-
transformed values of observed IgE
levels as quantitative dependent variable
(P¼0.011). In addition, both asthma
and rhinitis in the context of AD were
significantly associated (P¼ 2.5 106
and P¼2.4105 for combined geno-
type). Consistent with previous findings
(Weidinger et al., 2006), no association
was seen with the intrinsic subtype of
AD. Results of association analysis are
summarized in Table 2.
Our present findings confirm that
FLG mutations are strong risk factors for
AD, in particular for the extrinsic
subtype of AD, and with concomitant
respiratory allergic diseases. Our results
further indicate that these variations
predispose to an early onset and persis-
tent course of the disease. It seems
conceivable that a genetically deter-
mined primary epidermal barrier dis-
ruption is the key-event in AD that
predisposes to secondary allergic man-
ifestations by causing a reduced resis-
tance to environmental agents such as
allergens, irritants, and microbes. It will
be highly interesting to further evaluate
the epidermal differentiation complex
for additional candidate genes modu-
lating the skin barrier function.
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